/f/125658/7246x3240/f72d1f6fc5/esc-logo-lock-up-red-pos-rgb.png){kind=logo}
Screening for Atrial Fibrillation (AF) by handheld single-lead ECG and risk of all-cause mortality stratified by non-AF cardiovascular disease
Event: ESC Congress 2024
Topic: Sudden Death in Patients with Atrial Fibrillation
Session: Atrial fibrillation: what is associated with mortality?
Impact of resumption of Oral AntiCoagulation therapy (OAC) after GastroIntestinal Bleeding (GIB) on clinical outcomes in patients with Non-Valvular Atrial Fibrillation (NVAF)
Event: ESC Congress 2024
Topic: Oral Anticoagulation
Session: Oral anticoagulant therapy for atrial fibrillation in clinical practice
Impact of sodium-glucose co-transporter 2 inhibitors on cardiovascular outcomes in patients with chronic kidney disease: Hong Kong-wide, observational, propensity score matched analysis
Event: ESC Congress 2022
Topic: Renal Failure and Cardiovascular Disease
Session: Renal failure and cardiovascular disease 1
Impact of early initiation of SGLT2 inhibitor on cardiovascular outcomes in diabetic patients with known atherosclerotic cardiovascular disease or risk factors: propensity score matched analysis
Event: ESC Congress 2021 - The Digital Experience
Topic: Pharmacotherapy
Session: Can we improve outcomes by targeting metabolic risk?
